/Companies

AVATAR MEDICAL

Paris, FR · Founded 2020 · 46 employees on LinkedIn · 3 known investors

Find your way into AVATAR MEDICAL

Sign up to see every warm intro you have to AVATAR MEDICAL

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the AVATAR MEDICAL team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Avatar Medical builds software that converts medical images into interactive 3D "avatars" to help patients understand their conditions and support surgeons in planning procedures. Its products are used by hospitals and clinicians across multiple medical specialties for patient consultation, surgical planning, and medical education.

Founders & leadership

AVATAR MEDICAL was founded in 2020 by Xavier Wartelle.

XWXavier Wartelle
Xavier WartelleCo-Founder & CEOHe has held executive and founding roles across multiple sectors including med-tech, enterprise software, and telecom, and holds a Master of Science in Engineering from École nationale supérieure d'Arts et Métiers.

Investors · 3

Frequently asked questions

What does AVATAR MEDICAL do?
Avatar Medical builds software that converts medical images into interactive 3D "avatars" to help patients understand their conditions and support surgeons in planning procedures. Its products are used by hospitals and clinicians across multiple medical specialties for patient consultation, surgical planning, and medical education.
Who founded AVATAR MEDICAL?
AVATAR MEDICAL was founded by Xavier Wartelle in 2020.
Who are AVATAR MEDICAL's investors?
AVATAR MEDICAL's investors include Acorn Pacific Ventures, Plug and Play Ventures, Snatched Ventures.
Where is AVATAR MEDICAL headquartered?
AVATAR MEDICAL is headquartered in Paris, FR.